COMBINED TREATMENT WITH LHRH AGONIST AND PURE ANTIANDROGEN IN ADVANCED CARCINOMA OF PROSTATE
- 10 November 1984
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 324 (8411), 1090
- https://doi.org/10.1016/s0140-6736(84)91521-6
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Simultaneous administration of pure antiandrogens, a combination necessary for the use of luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer.Proceedings of the National Academy of Sciences, 1984
- DISEASE FLARE INDUCED BY D-Trp6-LHRH ANALOGUE IN PATIENTS WITH METASTATIC PROSTATIC CANCERThe Lancet, 1984
- Effect of very high dose D-leucine6-gonadotropin-releasing hormone proethylamide on the hypothalamic-pituitary testicular axis in patients with prostatic cancer.Journal of Clinical Investigation, 1983
- Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones aloneCancer, 1983
- Antifertility Effects of LHRH Agonists in the MaleJournal of Andrology, 1980
- Reconsideration of Orchiectomy in the Treatment of Advanced Prostatic CarcinomaSouthern Medical Journal, 1977
- ENDOCRINE CONTROL OF PROSTATIC CARCINOMAJAMA, 1950